特兰胺酸-脂肪酒精聚氧乙烯结合/PVA泡用于静脉硬化疗法通过血管损伤和抑制等离子体系统
Jizhuang Ma1, Keda Zhang2, Wenhan Li3
1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Acta pharmaceutica Sinica. B
|July 14, 2025
概括
使用双作用阴表面活性剂 (AEOx-TA) 的新型硬化疗法通过破坏血管和抑制凝块分解来提高静脉疾病的治疗疗效,提供更安全,更有效的替代方案.
科学领域:
- 血管医学 血管医学
- 生物材料科学 生物材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉系统疾病,如静脉,显著影响患者的健康和生活质量.
- 硬化疗是一种主要治疗方法,但患有不完全纤维化和再通道化,并存在不良事件的风险.
- 目前的硬化疗法策略需要加强,以提高安全性和疗效.
研究的目的:
- 开发一种新的硬化疗法策略,具有血管损伤和等离子体 (PLA) 系统抑制的双重机制.
- 合成和表征一种新的阴离子表面活性剂,AEOx-TA,以改善硬化疗法的结果.
- 创建一个稳定的泡配方,用于精确的药物输送和长时间的保留.
主要方法:
- 通过以键连接,合成了一种新型的阴阳性表面活性剂 (AEOx-TA),通过将特兰胺酸 (TA) 与脂肪酒精聚氧乙烯 (AEOx) 结合在一起.
- 研究了双重机制:血管内皮损伤和通过TA释放抑制PLA系统.
- 配制的AEOx-TA与聚乙醇 (PVA) 合成稳定的泡 (AEOx-TA/P) 以提高交付效果.
主要成果:
- AEOx-TA有效地损害了血管内皮并启动了血栓形成.
- 释放的TA抑制了PLA系统,防止了血栓和细胞外基质的降解,促进了纤维化.
- 该AEOx-TA/P泡配方证明了药物传递的精确性和延长的保留时间,提高了疗效并降低了栓塞风险.
结论:
- 新型阴离子表面活性剂AEOx-TA提供了一个有前途的新的硬化疗法策略.
- 这种双机制的方法解决了当前表面活性剂硬化剂的局限性,提高了效率和安全性.
- AEOx-TA/P泡配方在治疗静脉系统疾病方面取得了重大进展.
相关概念视频
Venous Thrombosis III: Interprofessional Care
25
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
25
Varicose Veins II: Diagnostic Studies and Interprofessional Care
35
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
35
Vascular Spasm
1.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
917
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
917
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Venous Thrombosis I: Introduction
43
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
43


